1 Mixed gastric infections and infection with other Helicobacter species --;2 In vivo studies of emergent issues in gastric Helicobacter pathogenesis and epidemiology --;3 Genetic bases for heterogeneity of Helicobacter pylori --;4 Mobilis in mobile: unexpected flexibility and quantum leaps in the Helicobacter pylori genome --;5 Effect of gastric acid on Helicobacter pylori ecology --;6 Helicobacter pylori and the gastric environment --;7 P-type ion motive ATPases of Helicobacter pylori --;8 Which is the most important factor in duodenal ulcer pathogenesis: the strain of Helicobacter pylori or the host? --;9 The effect of Helicobacter pylori on the surface hydrophobicity and phospholipid composition of the gastric mucosa --;10 Mediators of inflammation in Helicobacter pylori infection --;11 Effects of abnormalities of gastrin and somatostatin in Helicobacter pylori infection on acid secretion --;12 Helicobacter pylori gastritis and gastric acid secretory function --;an integrated approach --;13 Nitric oxide, bacteria and ulcer healing --;14 Effects of infection with Helicobacter pylori on gastric epithelium --;15 Is the Th1/Th2 lymphocyte balance upset by Helicobacter pylori infection? --;16 What determines the vigour of the immune response to Helicobacter pylori? --;17 Theories of vaccination for Helicobacter pylori --;18 Vaccines for the treatment and prevention of Helicobacter pylori infection --;19 The epithelial changes associated with Helicobacter pylori infection: the biology of gastric and intestinal metaplasia --;20 Cell regulation, differentiation and their sequelae in the Helicobacter pylori inflamed and eradicated stomach --;21 The gastric lymphomas and the role of Helicobacter pylori in tumour development: have criteria been set for diagnosis? --;22 Clinical presentation, diagnosis and treatment of Helicobacter pylori-related gastric lymphoma --;23 Mechanisms of paralysis and apoptosis of the inflammatory cells in Helicobacter pylori infection --;24 Lessons from the epidemiology of Helicobacter pylori and cancer --;25 Helicobacter pylori, acid, gastritis, atrophy and progression to cancer: a critical view --;26 Essential co-factors in gastric carcinogenesis --;27 Mechanisms of spread of Helicobacter pylori infection --;28 Whom, how and when to test for Helicobacter pylori infection --;29 Helicobacter pylori infection in children --;30 The problem ulcer; bleeding, perforation, Helicobacter pylori-negativity and intractability --;31 Role of Helicobacter pylori infection in gastro-oesophageal reflux disease (GERD) --;32 Are NSAIDs and Helicobacter pylori separate risk factors? --;33 Helicobacter pylori and dyspepsia --;a conceptual approach --;34 Aspects of anti-Helicobacter pylori eradication therapy --;35 What is the relevance of resistance of Helicobacter pylori to antimicrobial agents? --;36 Treatment of patients with failed eradication --;a personal view --;37 What is the role of the primary care physician in the treatment of Helicobacter pylori? --;38 Novel therapies for Helicobacter pylori infection --;39 Economic evaluation of Helicobacter pylori eradication in the management of duodenal ulcer --;40 Model of Helicobacter pylori treatment and disease outcome: a threshold analysis --;Winning Posters.
SUMMARY OR ABSTRACT
Text of Note
The impact of Helicobacter pylori on basic science and the clinical management of patients with the complications of this infection is bewildering.